Disease-specific, neurosphere-derived cells as models for brain disorders

DMM Disease Models and Mechanisms

Volumn 3, Issue 11-12, 2010, Pages 785-798

  Matigian, Nicholas ^a   Abrahamsen, Greger ^a   Sutharsan, Ratneswary ^a   Cook, Anthony L ^a   Vitale, Alejandra M ^a   Nouwens, Amanda ^b   Bellette, Bernadette ^a   An, Jiyuan ^a   Anderson, Matthew ^a   Beckhouse, Anthony G ^a   Bennebroek, Maikel ^a   Cecil, Rowena ^a   Chalk, Alistair M ^a   Cochrane, Julie ^a   Fan, Yongjun ^a   Féron, François ^a,f   McCurdy, Richard ^a,g   McGrath, John J ^a,b,c   Murrell, Wayne ^a,h   Perry, Chris ^a,d   Raju, Jyothy ^a   Ravishankar, Sugandha ^a   Silburn, Peter A ^a,b   Sutherland, Greg T ^a   Mahler, Stephen ^b   Mellick, George D ^a   Wood, Stephen A ^a   Sue, Carolyn M ^a,e   Wells, Christine A ^a   Mackay Sim, Alan ^a   more..

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^d PRINCESS ALEXANDRA HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f Mediterranée University   (France)

^g HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOPSY TECHNIQUE; CELL ADHESION; CELL FUNCTION; CELL GROWTH; CELL LINE; CELL REGENERATION; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYONIC STEM CELL; FIBROBLAST; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOCHONDRION; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; OLFACTORY EPITHELIUM; OXIDATIVE STRESS; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SMELLING; XENOBIOTIC METABOLISM;

BRAIN DISEASES; CELL LINE; CELL PROLIFERATION; CELL SHAPE; HUMANS; IMMUNOPHENOTYPING; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; NEURONS; OLFACTORY MUCOSA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARKINSON DISEASE; PHENOTYPE; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 78649284827     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.005447     Document Type: Article

References (83)

1. Abrams, M. T., Kaufmann, W. E., Rousseau, F., Oostra, B. A., Wolozin, B., Taylor, C. V., Lishaa, N., Morel, M. L., Hoogeveen, A. and Reiss, A. L. (1999). FMR1 gene expression in olfactory neuroblasts from two males with fragile X syndrome. Am. J. Med. Genet. 82, 25-30.
2. Arnold, S. E., Han, L. Y., Moberg, P. J., Turetsky, B. I., Gur, R. E., Trojanowski, J. Q. and Hahn, C. G. (2001). Dysregulation of olfactory receptor neuron lineage in schizophrenia. Arch. Gen. Psychiatry 58, 829-835.
3. Aston, C., Jiang, L. and Sokolov, B. P. (2004). Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J. Neurosci. Res 77, 858-866.
4. Benmoyal-Segal, L. and Soreq, H. (2006). Gene-environment interactions in sporadic Parkinson's disease. J. Neurochem. 97, 1740-1755. (Pubitemid 43873664)
5. Bolstad, B. M., Irizarry, R. A., Astrand, M. and Speed, T. P. (2003). A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193.
6. Brewer, W. J., Wood, S. J., McGorry, P. D., Francey, S. M., Phillips, L. J., Yung, A. R., Anderson, V., Copolov, D. L., Singh, B., Velakoulis, D. et al. (2003). Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am. J. Psychiatry 160, 1790-1794.
7. Brown, A. S. (2006). Prenatal infection as a risk factor for schizophrenia. Schizophr. Bull. 32, 200-202.
8. Brown, A. S., Hooton, J., Schaefer, C. A., Zhang, H., Petkova, E., Babulas, V., Perrin, M., Gorman, J. M. and Susser, E. S. (2004). Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am. J. Psychiatry 161, 889-895. (Pubitemid 38625343)
9. Castle, D. J., Jablensky, A., McGrath, J. J., Carr, V., Morgan, V., Waterreus, A., Valuri, G., Stain, H., McGuffin, P. and Farmer, A. (2006). The diagnostic interview for psychoses (DIP): development, reliability and applications. Psychol. Med. 36, 69-80.
10. Chen, X., Fang, H. and Schwob, J. E. (2004). Multipotency of purified, transplanted globose basal cells in olfactory epithelium. J. Comp. Neurol. 469, 457-474.
11. Colantuoni, C., Hyde, T. M., Mitkus, S., Joseph, A., Sartorius, L., Aguirre, C., Creswell, J., Johnson, E., Deep-Soboslay, A., Herman, M. M. et al. (2008). Agerelated changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex. Brain Struct. Funct. 213, 255-271.
12. Corfas, G., Roy, K. and Buxbaum, J. D. (2004). Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat. Neurosci. 7, 575-580.
13. Cuadrado, A., Moreno-Murciano, P. and Pedraza-Chaverri, J. (2009). The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease. Expert Opin. Ther. Targets 13, 319-329.
14. Delorme, B., Nivet, E., Gaillard, J., Haupl, T., Ringe, J., Deveze, A., Magnan, J., Sohier, J., Khrestchatisky, M., Roman, F. S. et al. (2010). The human nose harbours a niche of olfactory ectomesenchymal stem cells displaying neurogenic and osteogenic properties. Stem Cells Dev. 19, 853-866.
15. Denison, M. S. and Nagy, S. R. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309-334.
16. Dennis, G., Jr, Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C. and Lempicki, R. A. (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, P3.
17. Doty, R. L. (2009). The olfactory system and its disorders. Semin. Neurol. 29, 74-81.
18. Elvidge, G. (2006). BeadExplorer: QC, normalisation, annotation and exploration of Illumina BeadChip data. R package version 1.2.0. http://bioconductor.org/ packages/1.9/bioc/vignettes/BeadExplorer/inst/doc/ BeadHelp.pdf.
19. Erdely, H. A., Tamminga, C. A., Roberts, R. C. and Vogel, M. W. (2006). Regional alterations in RGS4 protein in schizophrenia. Synapse 59, 472-479.
20. Eyles, D., Brown, J., Mackay-Sim, A., McGrath, J. and Feron, F. (2003). Vitamin D3 and brain development. Neuroscience 118, 641-653.
21. Fatemi, S. H., Kroll, J. L. and Stary, J. M. (2001). Altered levels of Reelin and its isoforms in schizophrenia and mood disorders. NeuroReport 12, 3209-3215.
22. Féron, F., Perry, C., McGrath, J. J. and Mackay-Sim, A. (1998). New techniques for biopsy and culture of human olfactory epithelial neurons. Arch. Otolaryngol. Head Neck Surg. 124, 861-866.
23. Féron, F., Perry, C., Hirning, M. H., McGrath, J. and Mackay-Sim, A. (1999). Altered adhesion, proliferation and death in neural cultures from adults with schizophrenia. Schizophr. Res. 40, 211-218.
24. Feron, F., Burne, T. H., Brown, J., Smith, E., McGrath, J. J., Mackay-Sim, A. and Eyles, D. W. (2005). Developmental Vitamin D3 deficiency alters the adult rat brain. Brain Res. Bull. 65, 141-148.
25. Gautier, L., Cope, L., Bolstad, B. M. and Irizarry, R. A. (2004). affy - analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307-315.
26. Goodman, A. B. (1998). Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc. Natl. Acad. Sci. USA 95, 7240-7244.
27. Guidotti, A., Auta, J., Davis, J. M., Di-Giorgi-Gerevini, V., Dwivedi, Y., Grayson, D. R., Impagnatiello, F., Pandey, G., Pesold, C., Sharma, R. et al. (2000). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 57, 1061-1069.
28. Haehner, A., Boesveldt, S., Berendse, H. W., Mackay-Sim, A., Fleischmann, J., Silburn, P. A., Johnston, A. N., Mellick, G. D., Herting, B., Reichmann, H. et al. (2009). Prevalence of smell loss in Parkinson's disease-a multicenter study. Parkinsonism Relat. Disord. 15, 490-494.
29. Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V. and Fienberg, A. A. (2001). Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. USA 98, 4746-4751.
30. Harrison, P. J. (1999). The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122, 593-624.
31. Henchcliffe, C. and Beal, M. F. (2008). Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat. Clin. Pract. Neurol. 4, 600-609.
32. Hiesberger, T., Trommsdorff, M., Howell, B. W., Goffinet, A., Mumby, M. C., Cooper, J. A. and Herz, J. (1999). Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24, 481-489.
33. Hoepken, H. H., Gispert, S., Azizov, M., Klinkenberg, M., Ricciardi, F., Kurz, A., Morales-Gordo, B., Bonin, M., Riess, O., Gasser, T. et al. (2008). Parkinson patient fibroblasts show increased alpha-synuclein expression. Exp. Neurol. 212, 307-313.
34. Impagnatiello, F., Guidotti, A. R., Pesold, C., Dwivedi, Y., Caruncho, H., Pisu, M. G., Uzunov, D. P., Smalheiser, N. R., Davis, J. M., Pandey, G. N. et al. (1998). A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. USA 95, 15718-15723.
35. Jenner, P. (2008). Functional models of Parkinson's disease: a valuable tool in the development of novel therapies. Ann. Neurol. 64, S16-S29.
36. Kozlovsky, N., Belmaker, R. H. and Agam, G. (2000). Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am. J. Psychiatry 157, 831-833.
37. Kozlovsky, N., Regenold, W. T., Levine, J., Rapoport, A., Belmaker, R. H. and Agam, G. (2004). GSK-3beta in cerebrospinal fluid of schizophrenia patients. J. Neural. Transm. 111, 1093-1098.
38. LaMantia, A. S. (1999). Forebrain induction, retinoic acid, and vulnerability to schizophrenia: insights from molecular and genetic analysis in developing mice. Biol. Psychiatry 46, 19-30.
39. Lesage, S. and Brice, A. (2009). Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 18, R48-R59.
40. Leung, C. T., Coulombe, P. A. and Reed, R. R. (2007). Contribution of olfactory neural stem cells to tissue maintenance and regeneration. Nat. Neurosci. 10, 720-726.
41. Lewis, D. A. and Levitt, P. (2002). Schizophrenia as a disorder of neurodevelopment. Ann. Rev. Neurosci. 25, 409-432.
42. Lovestone, S., Killick, R., Di Forti, M. and Murray, R. (2007). Schizophrenia as a GSK-3 dysregulation disorder. Trends Neurosci. 30, 142-149.
43. Mackay-Sim, A. and Kittel, P. (1991). Cell dynamics in the adult mouse olfactory epithelium: a quantitative autoradiographic study. J. Neurosci. 11, 979-984.
44. Mackay-Sim, A. and Silburn, P. (2008). Stem cells and genetic disease. Cell Prolif. 41, 85-93.
45. Mahadik, S. P. and Mukherjee, S. (1996). Cultured skin fibroblasts as a cell model for investigating schizophrenia. J. Psychiatr. Res. 30, 421-439.
46. Marenco, S. and Weinberger, D. R. (2000). The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev. Psychopathol. 12, 501-527.
47. Martinez, A. and Soriano, E. (2005). Functions of ephrin/Eph interactions in the development of the nervous system: emphasis on the hippocampal system. Brain Res. Brain Res. Rev. 49, 211-226.
48. Mateizel, I., De Temmerman, N., Ullmann, U., Cauffman, G., Sermon, K., Van de Velde, H., De Rycke, M., Degreef, E., Devroey, P., Liebaers, I. et al. (2006). Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum. Reprod. 21, 503-511.
49. Matigian, N. A., McCurdy, R. D., Feron, F., Perry, C., Smith, H., Filippich, C., McLean, D., McGrath, J., Mackay-Sim, A., Mowry, B. et al. (2008). Fibroblast and lymphoblast gene expression profiles in schizophrenia: are non-neural cells informative? PLoS ONE 3, e2412.
50. McCurdy, R. D., Feron, F., Perry, C., Chant, D. C., McLean, D., Matigian, N., Hayward, N. K., McGrath, J. J. and Mackay-Sim, A. (2006). Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses. Schizophr. Res. 82, 163-173.
51. McGrath, J., Eyles, D., Mowry, B., Yolken, R. and Buka, S. (2003a). Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophr. Res. 63, 73-78.
52. McGrath, J. J., Feron, F. P., Burne, T. H., Mackay-Sim, A. and Eyles, D. W. (2003b). The neurodevelopmental hypothesis of schizophrenia: a review of recent developments. Ann. Med. 35, 86-93.
53. McGrath, J., Saari, K., Hakko, H., Jokelainen, J., Jones, P., Jarvelin, M. R., Chant, D. and Isohanni, M. (2004). Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr. Res. 67, 237-245.
54. McNaught, K. S. and Olanow, C. W. (2006). Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease. Neurobiol. Aging 27, 530-545.
55. Mellick, G. D. (2006). CYP450, genetics and Parkinson's disease: gene x environment interactions hold the key. J. Neural Transm. 2006, 159-165.
56. Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A. and Levitt, P. (2001). Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry 6, 293-301. (Pubitemid 32275674)
57. Miyamae, Y., Nakamura, Y., Kashiwagi, Y., Tanaka, T., Kudo, T. and Takeda, M. (1998). Altered adhesion efficiency and fibronectin content in fibroblasts from schizophrenic patients. Psychiatry Clin. Neurosci. 52, 345-352.
58. Murrell, W., Bushell, G. R., Livesey, J., McGrath, J., MacDonald, K. P. A., Bates, P. R. and Mackay-Sim, A. (1996). Neurogenesis in adult human. NeuroReport 7, 1189-1194.
59. Murrell, W., Feron, F., Wetzig, A., Cameron, N., Splatt, K., Bellette, B., Bianco, J., Perry, C., Lee, G. and Mackay-Sim, A. (2005). Multipotent stem cells from adult olfactory mucosa. Dev. Dyn. 233, 496-515.
60. Murrell, W., Wetzig, A., Donnellan, M., Feron, F., Burne, T., Meedeniya, A., Kesby, J., Bianco, J., Perry, C., Silburn, P. et al. (2008). Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease. Stem Cells 26, 2183-2192.
61. Murrell, W., Sanford, E., Anderberg, L., Cavanagh, B. and Mackay-Sim, A. (2009). Olfactory stem cells can be induced to express chondrogenic phenotype in a rat intervertebral disc injury model. Spine J. 9, 585-594.
62. Nie, L., Wu, G. and Zhang, W. (2006). Correlation between mRNA and protein abundance in Desulfovibrio vulgaris: a multiple regression to identify sources of variations. Biochem. Biophys. Res. Commun. 339, 603-610.
63. Othman, M., Lu, C., Klueber, K., Winstead, W. and Roisen, F. (2005). Clonal analysis of adult human olfactory neurosphere forming cells. Biotech. Histochem. 80, 189-200.
64. Park, I. H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K. and Daley, G. Q. (2008). Disease-specific induced pluripotent stem cells. Cell 134, 877-886.
65. Pascal, L. E., True, L. D., Campbell, D. S., Deutsch, E. W., Risk, M., Coleman, I. M., Eichner, L. J., Nelson, P. S. and Liu, A. Y. (2008). Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics 9, 246.
66. Pfaffl, M. W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45.
67. Pfaffl, M. W., Horgan, G. W. and Dempfle, L. (2002). Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36.
68. Raedler, T. J., Knable, M. B. and Weinberger, D. R. (1998). Schizophrenia as a developmental disorder of the cerebral cortex. Curr. Opin. Neurobiol. 8, 157-161.
69. Roisen, F. J., Klueber, K. M., Lu, C. L., Hatcher, L. M., Dozier, A., Shields, C. B. and Maguire, S. (2001). Adult human olfactory stem cells. Brain Res. 890, 11-22.
70. Ronnett, G. V., Leopold, D., Cai, X., Hoffbuhr, K. C., Moses, L., Hoffman, E. P. and Naidu, S. (2003). Olfactory biopsies demonstrate a defect in neuronal development in Rett's syndrome. Ann. Neurol. 54, 206-218.
71. Schmid, R. S., Jo, R., Shelton, S., Kreidberg, J. A. and Anton, E. S. (2005). Reelin, integrin and DAB1 interactions during embryonic cerebral cortical development. Cereb. Cortex 15, 1632-1636.
72. Summers, K. M. (1996). Relationship between genotype and phenotype in monogenic diseases: relevance to polygenic diseases. Hum. Mutat. 7, 283-293.
73. Sutherland, G. T., Matigian, N. A., Chalk, A. M., Anderson, M. J., Silburn, P. A., Mackay-Sim, A., Wells, C. A. and Mellick, G. D. (2009). A cross-study transcriptional analysis of Parkinson's disease. PLoS ONE 4, e4955.
74. Tkachev, D., Mimmack, M. L., Ryan, M. M., Wayland, M., Freeman, T., Jones, P. B., Starkey, M., Webster, M. J., Yolken, R. H. and Bahn, S. (2003). Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362, 798-805. (Pubitemid 37093922)
75. Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A. and Herz, J. (1999). Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97, 689-701.
76. Turetsky, B. I., Hahn, C. G., Borgmann-Winter, K. and Moberg, P. J. (2009). Scents and nonsense: olfactory dysfunction in schizophrenia. Schizophr. Bull. 35, 1117-1131.
77. Verlinsky, Y., Strelchenko, N., Kukharenko, V., Rechitsky, S., Verlinsky, O., Galat, V. and Kuliev, A. (2005). Human embryonic stem cell lines with genetic disorders. Reprod. Biomed. Online 10, 105-110.
78. Wang, L., Lockstone, H. E., Guest, P. C., Levin, Y., Palotas, A., Pietsch, S., Schwarz, E., Rahmoune, H., Harris, L. W., Ma, D. et al. (2009). Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia. J. Proteome Res. 9, 521-527.
79. Winkler-Stuck, K., Wiedemann, F. R., Wallesch, C. W. and Kunz, W. S. (2004). Effect of coenzyme Q(10) on the mitochondrial function of skin fibroblasts from Parkinson patients. J. Neurol. Sci. 220, 41-48.
80. Wolozin, B., Zheng, B., Loren, D., Lesch, K. P., Lebovics, R. S., Lieberburg, I. and Sunderland, T. (1992a). Beta/A4 domain of APP: antigenic differences between cell lines. J. Neurosci. Res. 33, 189-195.
81. Wolozin, B., Sunderland, T., Zheng, B. B., Resau, J., Dufy, B., Barker, J., Swerdlow, R. and Coon, H. (1992b). Continuous culture of neuronal cells from adult human olfactory epithelium. J. Mol. Neurosci. 3, 137-146.
82. Wray, N. R., Goddard, M. E. and Visscher, P. M. (2008). Prediction of individual genetic risk of complex disease. Curr. Opin. Genet. Dev. 18, 257-263.
83. Zaidel-Bar, R., Itzkovitz, S., Ma'ayan, A., Iyengar, R. and Geiger, B. (2007). Functional atlas of the integrin adhesome. Nat. Cell Biol. 9, 858-867.